Novartis Positive on Growth for 2024
Wall Street Journal
Novartis reported an almost 5% rise in core operating profit in the fourth quarter, with sales boosted by its heart and psoriasis drugs, and said it expected high single digit earnings growth in 2024.
https://www.wsj.com/articles/novartis-net-profit-boosted-by-gain-from-sandoz-spinoff-04d1025f